메뉴 건너뛰기




Volumn 20, Issue 2, 2016, Pages 277-292

Clinical Presentation and Patient Evaluation in Nonalcoholic Fatty Liver Disease

Author keywords

Evaluation; Nonalcoholic fatty liver; Steatohepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYTOKERATIN 18; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

EID: 84958213051     PISSN: 10893261     EISSN: 15578224     Source Type: Journal    
DOI: 10.1016/j.cld.2015.10.006     Document Type: Review
Times cited : (35)

References (78)
  • 1
    • 84861543083 scopus 로고    scopus 로고
    • The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
    • Chalasani N., Younossi Z., Lavine J., et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012, 55(6):2005-2023.
    • (2012) Hepatology , vol.55 , Issue.6 , pp. 2005-2023
    • Chalasani, N.1    Younossi, Z.2    Lavine, J.3
  • 2
    • 84886166367 scopus 로고    scopus 로고
    • The natural history of NAFLD
    • Wiley Blackwell Press, London, G.C. Farrell, A.J. McCullough, C.P. Day (Eds.)
    • Angulo P. The natural history of NAFLD. Non-alcoholic fatty liver disease: a practical guide 2013, 37-45. Wiley Blackwell Press, London. G.C. Farrell, A.J. McCullough, C.P. Day (Eds.).
    • (2013) Non-alcoholic fatty liver disease: a practical guide , pp. 37-45
    • Angulo, P.1
  • 3
    • 84923893879 scopus 로고    scopus 로고
    • Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States
    • Wong R.J., Aguilar M., Cheung R., et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology 2015, 148(3):547-555.
    • (2015) Gastroenterology , vol.148 , Issue.3 , pp. 547-555
    • Wong, R.J.1    Aguilar, M.2    Cheung, R.3
  • 4
    • 75449088414 scopus 로고    scopus 로고
    • Decreased survival of subjects with elevated liver function tests during a 28-year follow-up
    • Soderberg C., Stal P., Askling J., et al. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology 2010, 51:595-602.
    • (2010) Hepatology , vol.51 , pp. 595-602
    • Soderberg, C.1    Stal, P.2    Askling, J.3
  • 5
    • 79957521377 scopus 로고    scopus 로고
    • Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality
    • Younossi Z.M., Stepanova M., Rafiq N., et al. Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality. Hepatology 2011, 53:1874-1882.
    • (2011) Hepatology , vol.53 , pp. 1874-1882
    • Younossi, Z.M.1    Stepanova, M.2    Rafiq, N.3
  • 6
    • 10644220306 scopus 로고    scopus 로고
    • Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity
    • Browning J., Szczepaniak L., Dobbins R. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004, 40:1387-1395.
    • (2004) Hepatology , vol.40 , pp. 1387-1395
    • Browning, J.1    Szczepaniak, L.2    Dobbins, R.3
  • 7
    • 56649123256 scopus 로고    scopus 로고
    • The epidemiology of nonalcoholic fatty liver disease: a global perspective
    • Lazo M., Clark J. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis 2008, 28(4):339-350.
    • (2008) Semin Liver Dis , vol.28 , Issue.4 , pp. 339-350
    • Lazo, M.1    Clark, J.2
  • 8
    • 79960029926 scopus 로고    scopus 로고
    • Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
    • Vernon G., Baranova A., Younossi Z.M. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011, 34:274-285.
    • (2011) Aliment Pharmacol Ther , vol.34 , pp. 274-285
    • Vernon, G.1    Baranova, A.2    Younossi, Z.M.3
  • 9
    • 78650486196 scopus 로고    scopus 로고
    • Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study
    • Williams C., Stengel J., Asike M., et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011, 140(1):124-131.
    • (2011) Gastroenterology , vol.140 , Issue.1 , pp. 124-131
    • Williams, C.1    Stengel, J.2    Asike, M.3
  • 10
    • 57749183469 scopus 로고    scopus 로고
    • Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus
    • Leite N., Salles G., Araujo A., et al. Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus. Liver Int 2009, 29:113-119.
    • (2009) Liver Int , vol.29 , pp. 113-119
    • Leite, N.1    Salles, G.2    Araujo, A.3
  • 11
    • 0019152816 scopus 로고
    • Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease
    • Ludwig J., Viggiano T., McGill D., et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980, 55(7):434-438.
    • (1980) Mayo Clin Proc , vol.55 , Issue.7 , pp. 434-438
    • Ludwig, J.1    Viggiano, T.2    McGill, D.3
  • 12
    • 22344452893 scopus 로고    scopus 로고
    • The natural history of nonalcoholic fatty liver disease: a population-based cohort study
    • Adams L., Lymp J., St Sauver J., et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005, 129:113-121.
    • (2005) Gastroenterology , vol.129 , pp. 113-121
    • Adams, L.1    Lymp, J.2    St Sauver, J.3
  • 13
    • 84887025674 scopus 로고    scopus 로고
    • Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients
    • Noureddin M., Yates K.P., Vaughn I.A., NASH CRN, et al. Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients. Hepatology 2013, 58(5):1644-1654.
    • (2013) Hepatology , vol.58 , Issue.5 , pp. 1644-1654
    • Noureddin, M.1    Yates, K.P.2    Vaughn, I.A.3    NASH, CRN4
  • 14
    • 34347389654 scopus 로고    scopus 로고
    • Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center
    • Lee J., Kim K., Lee S.G., et al. Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center. J Hepatol 2007, 47(2):239-244.
    • (2007) J Hepatol , vol.47 , Issue.2 , pp. 239-244
    • Lee, J.1    Kim, K.2    Lee, S.G.3
  • 15
    • 0034659943 scopus 로고    scopus 로고
    • Selection and outcome of living donors for adult to adult right lobe transplantation
    • Marcos A., Fischer R., Ham J.M. Selection and outcome of living donors for adult to adult right lobe transplantation. Transplantation 2000, 69:2410-2415.
    • (2000) Transplantation , vol.69 , pp. 2410-2415
    • Marcos, A.1    Fischer, R.2    Ham, J.M.3
  • 16
    • 34247605492 scopus 로고    scopus 로고
    • Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients
    • Targher G., Bertolini L., Padovani R., et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 2007, 30:1212-1218.
    • (2007) Diabetes Care , vol.30 , pp. 1212-1218
    • Targher, G.1    Bertolini, L.2    Padovani, R.3
  • 17
    • 0033739433 scopus 로고    scopus 로고
    • Fatty infiltration of liver in hyperlipidemic patients
    • Assy N., Kaita K., Mymin D., et al. Fatty infiltration of liver in hyperlipidemic patients. Dig Dis Sci 2000, 45:1929-1934.
    • (2000) Dig Dis Sci , vol.45 , pp. 1929-1934
    • Assy, N.1    Kaita, K.2    Mymin, D.3
  • 18
    • 34147168713 scopus 로고    scopus 로고
    • Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome
    • Gambarin-Gelwan M., Kinkhabwala S., Schiano T., et al. Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. Clin Gastroenterol Hepatol 2007, 5(4):496-501.
    • (2007) Clin Gastroenterol Hepatol , vol.5 , Issue.4 , pp. 496-501
    • Gambarin-Gelwan, M.1    Kinkhabwala, S.2    Schiano, T.3
  • 19
    • 0037396722 scopus 로고    scopus 로고
    • Effects of obstructive sleep apnea syndrome on serum aminotransferase levels in obese patients
    • Chin K., Nakamura T., Takahashi K., et al. Effects of obstructive sleep apnea syndrome on serum aminotransferase levels in obese patients. Am J Med 2003, 114:370-376.
    • (2003) Am J Med , vol.114 , pp. 370-376
    • Chin, K.1    Nakamura, T.2    Takahashi, K.3
  • 20
    • 30844460632 scopus 로고    scopus 로고
    • Symptoms of obstructive sleep apnea in patients with nonalcoholic fatty liver disease
    • Singh H., Pollock R., Uhanova J. Symptoms of obstructive sleep apnea in patients with nonalcoholic fatty liver disease. Dig Dis Sci 2005, 50(12):2338-2343.
    • (2005) Dig Dis Sci , vol.50 , Issue.12 , pp. 2338-2343
    • Singh, H.1    Pollock, R.2    Uhanova, J.3
  • 21
    • 84884839737 scopus 로고    scopus 로고
    • Ectopic fat: the true culprit linking obesity and cardiovascular disease?
    • Moreli M., Gaggini M., Daniel G., et al. Ectopic fat: the true culprit linking obesity and cardiovascular disease?. Thromb Haemost 2013, 110:651-660.
    • (2013) Thromb Haemost , vol.110 , pp. 651-660
    • Moreli, M.1    Gaggini, M.2    Daniel, G.3
  • 22
    • 79956117037 scopus 로고    scopus 로고
    • Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity
    • Fracanzani A., Valenti L., Bugianesi E., et al. Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity. J Hepatol 2011, 54:1244-1249.
    • (2011) J Hepatol , vol.54 , pp. 1244-1249
    • Fracanzani, A.1    Valenti, L.2    Bugianesi, E.3
  • 23
    • 36349006497 scopus 로고    scopus 로고
    • The impact of fat distribution on the severity of nonalcoholic fatty liver disease and metabolic syndrome
    • Cheung O., Kapoor A., Puri P., et al. The impact of fat distribution on the severity of nonalcoholic fatty liver disease and metabolic syndrome. Hepatology 2007, 46:1091-1100.
    • (2007) Hepatology , vol.46 , pp. 1091-1100
    • Cheung, O.1    Kapoor, A.2    Puri, P.3
  • 24
    • 42549164262 scopus 로고    scopus 로고
    • Fast-food-based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects
    • Kechagias S., Ernersson A., Dahlqvist O., et al. Fast-food-based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects. Gut 2008, 57:649-654.
    • (2008) Gut , vol.57 , pp. 649-654
    • Kechagias, S.1    Ernersson, A.2    Dahlqvist, O.3
  • 25
    • 84918504185 scopus 로고    scopus 로고
    • Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy
    • Wong V., Wong G., Yeung D., et al. Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy. J Hepatol 2015, 62:182-189.
    • (2015) J Hepatol , vol.62 , pp. 182-189
    • Wong, V.1    Wong, G.2    Yeung, D.3
  • 26
    • 84869498671 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease in lean individuals in the United States
    • Younossi Z., Stepanova M., Negro F., et al. Nonalcoholic fatty liver disease in lean individuals in the United States. Medicine (Baltimore) 2012, 91(6):319-327.
    • (2012) Medicine (Baltimore) , vol.91 , Issue.6 , pp. 319-327
    • Younossi, Z.1    Stepanova, M.2    Negro, F.3
  • 27
    • 0036247430 scopus 로고    scopus 로고
    • Drugs and steatohepatitis
    • Farrell G. Drugs and steatohepatitis. Semin Liver Dis 2002, 22(2):185-194.
    • (2002) Semin Liver Dis , vol.22 , Issue.2 , pp. 185-194
    • Farrell, G.1
  • 28
    • 0038385250 scopus 로고    scopus 로고
    • Drug-induced steatohepatitis
    • Stravitz R., Sanyal A. Drug-induced steatohepatitis. Clin Liver Dis 2003, 7(2):435-451.
    • (2003) Clin Liver Dis , vol.7 , Issue.2 , pp. 435-451
    • Stravitz, R.1    Sanyal, A.2
  • 29
    • 84884915072 scopus 로고    scopus 로고
    • Drug-induced steatohepatitis
    • Patel V., Sanyal A. Drug-induced steatohepatitis. Clin Liver Dis 2013, 17(4):5333-5346.
    • (2013) Clin Liver Dis , vol.17 , Issue.4 , pp. 5333-5346
    • Patel, V.1    Sanyal, A.2
  • 30
    • 33749365193 scopus 로고    scopus 로고
    • Utility of a new model to diagnose an alcohol basis for steatohepatitis
    • Dunn W., Angulo P., Sanderson S. Utility of a new model to diagnose an alcohol basis for steatohepatitis. Gastroenterology 2006, 131(4):1057-1063.
    • (2006) Gastroenterology , vol.131 , Issue.4 , pp. 1057-1063
    • Dunn, W.1    Angulo, P.2    Sanderson, S.3
  • 31
    • 84873674120 scopus 로고    scopus 로고
    • Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study
    • Loomba R., Yang H.I., Su J., et al. Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study. Am J Epidemiol 2013, 177(4):333-342.
    • (2013) Am J Epidemiol , vol.177 , Issue.4 , pp. 333-342
    • Loomba, R.1    Yang, H.I.2    Su, J.3
  • 32
    • 84893740725 scopus 로고    scopus 로고
    • Modest alcohol consumption decreases the risk of non-alcoholic fatty liver disease: a meta-analysis of 43 175 individuals
    • Sookoian S., Castaño G.O., Pirola C.J. Modest alcohol consumption decreases the risk of non-alcoholic fatty liver disease: a meta-analysis of 43 175 individuals. Gut 2014, 63(3):530-532.
    • (2014) Gut , vol.63 , Issue.3 , pp. 530-532
    • Sookoian, S.1    Castaño, G.O.2    Pirola, C.J.3
  • 33
    • 3242798959 scopus 로고    scopus 로고
    • Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C
    • Poynard T., Munteanu M., Imbert-Bismut F., et al. Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clin Chem 2004, 50(8):1344-1355.
    • (2004) Clin Chem , vol.50 , Issue.8 , pp. 1344-1355
    • Poynard, T.1    Munteanu, M.2    Imbert-Bismut, F.3
  • 34
    • 62849123229 scopus 로고    scopus 로고
    • Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic fatty liver disease
    • Vuppalanchi R., Unalp A., Van Natta M., et al. Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2009, 7(4):481-486.
    • (2009) Clin Gastroenterol Hepatol , vol.7 , Issue.4 , pp. 481-486
    • Vuppalanchi, R.1    Unalp, A.2    Van Natta, M.3
  • 36
    • 0029778988 scopus 로고    scopus 로고
    • An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group
    • Bedossa P., Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996, 24(2):289-293.
    • (1996) Hepatology , vol.24 , Issue.2 , pp. 289-293
    • Bedossa, P.1    Poynard, T.2
  • 37
    • 84902651902 scopus 로고    scopus 로고
    • Radiologic evaluation of nonalcoholic fatty liver disease
    • Lee S.S., Park S.H. Radiologic evaluation of nonalcoholic fatty liver disease. World J Gastroenterol 2014, 20:7392-7402.
    • (2014) World J Gastroenterol , vol.20 , pp. 7392-7402
    • Lee, S.S.1    Park, S.H.2
  • 39
    • 36448976537 scopus 로고    scopus 로고
    • Interobserver and intraobserver variability in the sonographic assessment of fatty liver
    • Strauss S., Gavish E., Gottlieb P., et al. Interobserver and intraobserver variability in the sonographic assessment of fatty liver. AJR Am J Roentgenol 2007, 189(6):W320-W323.
    • (2007) AJR Am J Roentgenol , vol.189 , Issue.6 , pp. W320-W323
    • Strauss, S.1    Gavish, E.2    Gottlieb, P.3
  • 40
    • 84908467011 scopus 로고    scopus 로고
    • Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease
    • Fedchuk L., Nascimbeni F., Pais R., et al. Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease. Aliment Pharmacol Ther 2014, 40:1209-1222.
    • (2014) Aliment Pharmacol Ther , vol.40 , pp. 1209-1222
    • Fedchuk, L.1    Nascimbeni, F.2    Pais, R.3
  • 41
    • 77955828718 scopus 로고    scopus 로고
    • A simple index of lipid overaccumulation is a good marker of liver steatosis
    • Bedogni G., Kahn H.S., Bellentani S., et al. A simple index of lipid overaccumulation is a good marker of liver steatosis. BMC Gastroenterol 2010, 10:98.
    • (2010) BMC Gastroenterol , vol.10 , pp. 98
    • Bedogni, G.1    Kahn, H.S.2    Bellentani, S.3
  • 42
    • 84882845563 scopus 로고    scopus 로고
    • External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study
    • Koehler E.M., Schouten J.N., Hansen B.E., et al. External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study. Clin Gastroenterol Hepatol 2013, 11(9):1201-1204.
    • (2013) Clin Gastroenterol Hepatol , vol.11 , Issue.9 , pp. 1201-1204
    • Koehler, E.M.1    Schouten, J.N.2    Hansen, B.E.3
  • 43
    • 84927698587 scopus 로고    scopus 로고
    • Validation of noninvasive methods for detecting hepatic steatosis in patients with human immunodeficiency virus infection
    • Siddiqui M.S., Patidar K.R., Boyett S., et al. Validation of noninvasive methods for detecting hepatic steatosis in patients with human immunodeficiency virus infection. Clin Gastroenterol Hepatol 2015, 13(2):402-405.
    • (2015) Clin Gastroenterol Hepatol , vol.13 , Issue.2 , pp. 402-405
    • Siddiqui, M.S.1    Patidar, K.R.2    Boyett, S.3
  • 44
    • 84904327497 scopus 로고    scopus 로고
    • Comparison of microwave ablation and surgical resection for treatment of hepatocellular carcinomas conforming to Milan criteria
    • Shi J., Sun Q., Wang Y., et al. Comparison of microwave ablation and surgical resection for treatment of hepatocellular carcinomas conforming to Milan criteria. J Gastroenterol Hepatol 2014, 29(7):1500-1507.
    • (2014) J Gastroenterol Hepatol , vol.29 , Issue.7 , pp. 1500-1507
    • Shi, J.1    Sun, Q.2    Wang, Y.3
  • 45
    • 84898827951 scopus 로고    scopus 로고
    • Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations
    • de Lédinghen V., Vergniol J., Capdepont M., et al. Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations. J Hepatol 2014, 60(5):1026-1031.
    • (2014) J Hepatol , vol.60 , Issue.5 , pp. 1026-1031
    • de Lédinghen, V.1    Vergniol, J.2    Capdepont, M.3
  • 46
    • 0037566201 scopus 로고    scopus 로고
    • Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values
    • Mofrad P., Contos M., Haque M., et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 2003, 37(6):1286-1292.
    • (2003) Hepatology , vol.37 , Issue.6 , pp. 1286-1292
    • Mofrad, P.1    Contos, M.2    Haque, M.3
  • 47
    • 51349083814 scopus 로고    scopus 로고
    • Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes
    • Fracanzani A.L., Valenti L., Bugianesi E., et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology 2008, 48:792-798.
    • (2008) Hepatology , vol.48 , pp. 792-798
    • Fracanzani, A.L.1    Valenti, L.2    Bugianesi, E.3
  • 49
    • 52649112178 scopus 로고    scopus 로고
    • Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease
    • Harrison S.A., Oliver D., Arnold H.L., et al. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut 2008, 57(10):1441-1447.
    • (2008) Gut , vol.57 , Issue.10 , pp. 1441-1447
    • Harrison, S.A.1    Oliver, D.2    Arnold, H.L.3
  • 50
    • 34247384560 scopus 로고    scopus 로고
    • The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD
    • Angulo P., Hui J.M., Marchesini G., et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 2007, 45(4):846.
    • (2007) Hepatology , vol.45 , Issue.4 , pp. 846
    • Angulo, P.1    Hui, J.M.2    Marchesini, G.3
  • 51
    • 33745547388 scopus 로고    scopus 로고
    • Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection
    • Sterling R., Lissen E., Clumeck N., et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006, 43(6):1317-1325.
    • (2006) Hepatology , vol.43 , Issue.6 , pp. 1317-1325
    • Sterling, R.1    Lissen, E.2    Clumeck, N.3
  • 52
    • 70349546276 scopus 로고    scopus 로고
    • Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease
    • Shah A.G., Lydecker A., Murray K., et al. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2009, 7(10):1104.
    • (2009) Clin Gastroenterol Hepatol , vol.7 , Issue.10 , pp. 1104
    • Shah, A.G.1    Lydecker, A.2    Murray, K.3
  • 53
    • 84884416525 scopus 로고    scopus 로고
    • Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease
    • Angulo P., Bugianesi E., Bjornsson E.S., et al. Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology 2013, 145(4):782.
    • (2013) Gastroenterology , vol.145 , Issue.4 , pp. 782
    • Angulo, P.1    Bugianesi, E.2    Bjornsson, E.S.3
  • 54
    • 84874778141 scopus 로고    scopus 로고
    • The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease
    • Cichoz-Lach H., Celiński K., Prozorow-Król B., et al. The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease. Med Sci Monit 2012, 18(12):CR735-CR740.
    • (2012) Med Sci Monit , vol.18 , Issue.12 , pp. CR735-CR740
    • Cichoz-Lach, H.1    Celiński, K.2    Prozorow-Król, B.3
  • 55
    • 56949084285 scopus 로고    scopus 로고
    • Comparison of blood tests for liver fibrosis specific or not to NAFLD
    • Calès P., Lainé F., Boursier J., et al. Comparison of blood tests for liver fibrosis specific or not to NAFLD. J Hepatol 2009, 50(1):165-173.
    • (2009) J Hepatol , vol.50 , Issue.1 , pp. 165-173
    • Calès, P.1    Lainé, F.2    Boursier, J.3
  • 56
    • 38049125477 scopus 로고    scopus 로고
    • Meta-analyses of FibroTest diagnostic value in chronic liver disease
    • Poynard T., Morra R., Halfon P., et al. Meta-analyses of FibroTest diagnostic value in chronic liver disease. BMC Gastroenterol 2007, 7:40.
    • (2007) BMC Gastroenterol , vol.7 , pp. 40
    • Poynard, T.1    Morra, R.2    Halfon, P.3
  • 57
    • 84858224449 scopus 로고    scopus 로고
    • Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient data
    • Poynard T., Lassailly G., Diaz E., et al. Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient data. PLoS One 2012, 7:e30325.
    • (2012) PLoS One , vol.7 , pp. e30325
    • Poynard, T.1    Lassailly, G.2    Diaz, E.3
  • 58
    • 84891889855 scopus 로고    scopus 로고
    • Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease-the role of transient elastography and plasma cytokeratin-18 fragments
    • Kwok R., Tse Y.K., Wong G.L., et al. Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease-the role of transient elastography and plasma cytokeratin-18 fragments. Aliment Pharmacol Ther 2014, 39(3):254-269.
    • (2014) Aliment Pharmacol Ther , vol.39 , Issue.3 , pp. 254-269
    • Kwok, R.1    Tse, Y.K.2    Wong, G.L.3
  • 59
    • 9644279531 scopus 로고    scopus 로고
    • Serum markers detect the presence of liver fibrosis: a cohort study
    • Rosenberg W.M., Voelker M., Thiel R., et al. Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 2004, 127(6):1704-1713.
    • (2004) Gastroenterology , vol.127 , Issue.6 , pp. 1704-1713
    • Rosenberg, W.M.1    Voelker, M.2    Thiel, R.3
  • 60
    • 39549118158 scopus 로고    scopus 로고
    • Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European Liver Fibrosis Panel and exploring simple markers
    • Guha I.N., Parkes J., Roderick P., et al. Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European Liver Fibrosis Panel and exploring simple markers. Hepatology 2008, 47:455-460.
    • (2008) Hepatology , vol.47 , pp. 455-460
    • Guha, I.N.1    Parkes, J.2    Roderick, P.3
  • 61
    • 33745904468 scopus 로고    scopus 로고
    • In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease
    • Wieckowska A., Zein N.N., Yerian L.M., et al. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology 2006, 44:27-33.
    • (2006) Hepatology , vol.44 , pp. 27-33
    • Wieckowska, A.1    Zein, N.N.2    Yerian, L.M.3
  • 62
    • 70350046669 scopus 로고    scopus 로고
    • Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study
    • Feldstein A., Wieckowska A., Rocio Lopez A., et al. Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study. Hepatology 2009, 50(4):1072-1078.
    • (2009) Hepatology , vol.50 , Issue.4 , pp. 1072-1078
    • Feldstein, A.1    Wieckowska, A.2    Rocio Lopez, A.3
  • 63
    • 33947528311 scopus 로고    scopus 로고
    • Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis
    • Yilmaz Y., Dolar E., Ulukaya E., et al. Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis. World J Gastroenterol 2007, 13:837-844.
    • (2007) World J Gastroenterol , vol.13 , pp. 837-844
    • Yilmaz, Y.1    Dolar, E.2    Ulukaya, E.3
  • 64
    • 0030832858 scopus 로고    scopus 로고
    • What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy
    • Gaiani S., Gramantieri L., Venturoli N., et al. What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy. J Hepatol 1997, 27(6):979-985.
    • (1997) J Hepatol , vol.27 , Issue.6 , pp. 979-985
    • Gaiani, S.1    Gramantieri, L.2    Venturoli, N.3
  • 65
    • 84872682192 scopus 로고    scopus 로고
    • Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver-update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS
    • Claudon M., Dietrich C.F., Choi B.I., et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver-update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall Med 2013, 34(1):11-29.
    • (2013) Ultraschall Med , vol.34 , Issue.1 , pp. 11-29
    • Claudon, M.1    Dietrich, C.F.2    Choi, B.I.3
  • 66
    • 75449091784 scopus 로고    scopus 로고
    • Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease
    • Wong V.W., Vergniol J., Wong G.L., et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 2010, 51:454-462.
    • (2010) Hepatology , vol.51 , pp. 454-462
    • Wong, V.W.1    Vergniol, J.2    Wong, G.L.3
  • 67
    • 84860389114 scopus 로고    scopus 로고
    • Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease
    • Palmeri M.L., Wang M.H., Rouze N.C., et al. Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease. J Hepatol 2011, 55:666-672.
    • (2011) J Hepatol , vol.55 , pp. 666-672
    • Palmeri, M.L.1    Wang, M.H.2    Rouze, N.C.3
  • 68
    • 84881552256 scopus 로고    scopus 로고
    • Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis
    • Bota S., Herkner H., Sporea I., et al. Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis. Liver Int 2013, 33(8):1138-1147.
    • (2013) Liver Int , vol.33 , Issue.8 , pp. 1138-1147
    • Bota, S.1    Herkner, H.2    Sporea, I.3
  • 69
    • 84857520241 scopus 로고    scopus 로고
    • Ultrasound-based transient elastography for the detection of hepatic fibrosis in patients with recurrent hepatitis C virus after liver transplantation: a systematic review and meta-analysis
    • Adebajo C., Talwalkar J., Poterucha J., et al. Ultrasound-based transient elastography for the detection of hepatic fibrosis in patients with recurrent hepatitis C virus after liver transplantation: a systematic review and meta-analysis. Liver Transpl 2012, 18(3):323-331.
    • (2012) Liver Transpl , vol.18 , Issue.3 , pp. 323-331
    • Adebajo, C.1    Talwalkar, J.2    Poterucha, J.3
  • 70
    • 84876116484 scopus 로고    scopus 로고
    • EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 1: basic principles and technology
    • Bamber J., Cosgrove D., Dietrich C.F., et al. EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 1: basic principles and technology. Ultraschall Med 2013, 34(2):169-184.
    • (2013) Ultraschall Med , vol.34 , Issue.2 , pp. 169-184
    • Bamber, J.1    Cosgrove, D.2    Dietrich, C.F.3
  • 71
    • 84155188892 scopus 로고    scopus 로고
    • Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients
    • Myers R.P., Pomier-Layrargues G., Kirsch R., et al. Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology 2012, 55(1):199-208.
    • (2012) Hepatology , vol.55 , Issue.1 , pp. 199-208
    • Myers, R.P.1    Pomier-Layrargues, G.2    Kirsch, R.3
  • 72
    • 46049100990 scopus 로고    scopus 로고
    • Magnetic resonance elastography for the noninvasive staging of liver fibrosis
    • Huwart L., Sempoux C., Vicaut E., et al. Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology 2008, 135(1):32.
    • (2008) Gastroenterology , vol.135 , Issue.1 , pp. 32
    • Huwart, L.1    Sempoux, C.2    Vicaut, E.3
  • 73
    • 84911948591 scopus 로고    scopus 로고
    • Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study
    • Loomba R., Wolfson T., Ang B., et al. Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study. Hepatology 2014, 60:1920-1928.
    • (2014) Hepatology , vol.60 , pp. 1920-1928
    • Loomba, R.1    Wolfson, T.2    Ang, B.3
  • 74
    • 79956292596 scopus 로고    scopus 로고
    • Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography
    • Chen J., Talwalkar J., Yin M., et al. Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology 2011, 259(3):749-756.
    • (2011) Radiology , vol.259 , Issue.3 , pp. 749-756
    • Chen, J.1    Talwalkar, J.2    Yin, M.3
  • 75
    • 12144259379 scopus 로고    scopus 로고
    • Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population
    • Szczepaniak L.S., Nurenberg P., Leonard D., et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2005, 288(2):E462-E468.
    • (2005) Am J Physiol Endocrinol Metab , vol.288 , Issue.2 , pp. E462-E468
    • Szczepaniak, L.S.1    Nurenberg, P.2    Leonard, D.3
  • 76
    • 84922326013 scopus 로고    scopus 로고
    • Use of liver breath tests to assess severity of nonalcoholic fatty liver disease
    • Furnari M., Savarino V., Giannini E. Use of liver breath tests to assess severity of nonalcoholic fatty liver disease. Rev Recent Clin Trials 2014, 9(3):178-184.
    • (2014) Rev Recent Clin Trials , vol.9 , Issue.3 , pp. 178-184
    • Furnari, M.1    Savarino, V.2    Giannini, E.3
  • 77
    • 80052387485 scopus 로고    scopus 로고
    • Non-invasive estimation of liver fibrosis in non-alcoholic fatty liver disease using the 13 C-caffeine breath test
    • Park G., Wiseman E., George J., et al. Non-invasive estimation of liver fibrosis in non-alcoholic fatty liver disease using the 13 C-caffeine breath test. J Gastroenterol Hepatol 2011, 26:1411-1416.
    • (2011) J Gastroenterol Hepatol , vol.26 , pp. 1411-1416
    • Park, G.1    Wiseman, E.2    George, J.3
  • 78
    • 79960232654 scopus 로고    scopus 로고
    • The non-invasive (13)C-methionine breath test detects hepatic mitochondrial dysfunction as a marker of disease activity in non-alcoholic steatohepatitis
    • Banasch M., Ellrichmann M., Tannapfel A., et al. The non-invasive (13)C-methionine breath test detects hepatic mitochondrial dysfunction as a marker of disease activity in non-alcoholic steatohepatitis. Eur J Med Res 2011, 16:258-264.
    • (2011) Eur J Med Res , vol.16 , pp. 258-264
    • Banasch, M.1    Ellrichmann, M.2    Tannapfel, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.